Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos

• DOI: 10.1016/j.molcel.2024.07.007
• Publication Date: 2024-08-02T14:33:18Z
• Authors: Niannian Xue; Dishan Hong; Dan Zhang; Qian Wang; Shun Zhang; Lei Yang; Xi Chen; Yongmei Li; Honghui Han; Chunyi Hu; Mingyao Liu; Gaojie Song; Yuting Guan; Liren Wang; Yifan Zhu; Dali Li
• Keywords: Gene Editing; Mice; HEK293 Cells; Animals; Humans; CRISPR-Cas Systems; Embryo, Mammalian; Protein Engineering

The IscB proteins, as the ancestors of Cas9 endonuclease, hold great promise due to their small size and potential for diverse genome editing. However, their activity in mammalian cells is unsatisfactory. By introducing three residual substitutions in IscB, we observed an average 7.5-fold increase in activity. Through fusing a sequence-non-specific DNA-binding protein domain, the eIscB-D variant achieved higher editing efficiency, with a maximum of 91.3%. Moreover, engineered ωRNA was generated with a 20% reduction in length and slightly increased efficiency. The engineered eIscB-D/eωRNA system showed an average 20.2-fold increase in activity compared with the original IscB. Furthermore, we successfully adapted eIscB-D for highly efficient cytosine and adenine base editing. Notably, eIscB-D is highly active in mouse cell lines and embryos, enabling the efficient generation of disease models through mRNA/ωRNA injection. Our study suggests that these miniature genome-editing tools have great potential for diverse applications.